Do β2 microglobulin levels affect survival of newly diagnosed myeloma patients with translocation t(4;14) or 17p13 deletion treated with conventional chemotherapy?

W. J. Chng; S. Jacobus; R. Fonseca

doi:10.1038/sj.leu.2405009

Do β2 microglobulin levels affect survival of newly diagnosed myeloma patients with translocation t(4;14) or 17p13 deletion treated with conventional chemotherapy?

W. J. Chng, S. Jacobus, R. Fonseca

Hematology/Oncology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1080-1081
Number of pages	2
Journal	Leukemia
Volume	22
Issue number	5
DOIs	https://doi.org/10.1038/sj.leu.2405009
State	Published - May 2008

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/sj.leu.2405009

Cite this

@article{d8b7a98037744c5983446266373f8834,

title = "Do β2 microglobulin levels affect survival of newly diagnosed myeloma patients with translocation t(4;14) or 17p13 deletion treated with conventional chemotherapy?",

author = "Chng, {W. J.} and S. Jacobus and R. Fonseca",

year = "2008",

month = may,

doi = "10.1038/sj.leu.2405009",

language = "English (US)",

volume = "22",

pages = "1080--1081",

journal = "Leukemia",

issn = "0887-6924",